Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.

Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- CheckyesterdayChange DetectedThe page has been updated to reflect a new version (v2.16.5) and the removal of a previous update regarding the modernization of ClinicalTrials.gov data ingest. The estimated last update notice has also been deleted.SummaryDifference0.8%
- Check8 days agoChange DetectedThe page has been updated with new dates for updates and clinical trial information, including a new overall response rate (ORR) definition and methodology, while some previous dates and definitions have been removed.SummaryDifference2%
- Check15 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.